CorMedix Inc. (CRMD): Revenue
$311.71M
Year ended 2025-12-31
n/m
3-year compound annual growth
n/m
5-year compound annual growth
n/m
10-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $311.71M | +617.0% | 2026-03-05, From 2025-01-01 |
| 2024-12-31 | $43.47M | n/a | 2026-03-05, From 2024-01-01 |
| No annual figure between 2022-12-31 and 2024-12-31. | |||
| 2022-12-31 | $65.4K | -65.7% | 2024-03-12, From 2022-01-01 |
| 2021-12-31 | $190.9K | -20.2% | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | $239.2K | -15.5% | 2022-03-29, From 2020-01-01 |
| 2019-12-31 | $283.3K | -34.1% | 2021-03-30, From 2019-01-01 |
| 2018-12-31 | $429.8K | +30.5% | 2020-03-16, From 2018-01-01 |
| 2017-12-31 | $329.3K | +47.0% | 2019-05-29, From 2017-01-01 |
| 2016-12-31 | $224.1K | +6.7% | 2018-03-19, From 2016-01-01 |
| 2015-12-31 | $210.1K | +11.0% | 2017-03-16, From 2015-01-01 |
| 2014-12-31 | $189.3K | n/m | 2017-03-16, From 2014-01-01 |
| 2013-12-31 | $2.0K | n/a | 2015-03-12, From 2013-01-01 |
| 2012-12-31 | $0 | n/a | 2014-03-31, From 2012-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| CorMedix Inc. (CRMD) | 2025-12-31 | $311.71M | +617.0% |
| Evolus, Inc. (EOLS) | 2025-12-31 | $297.18M | +11.6% |
| Ironwood Pharmaceuticals Inc (IRWD) | 2025-12-31 | $296.15M | -15.7% |
| Xeris Biopharma Holdings, Inc. (XERS) | 2025-12-31 | $291.85M | +43.7% |
| MannKind Corp (MNKD) | 2025-12-31 | $348.97M | +22.2% |
| Harrow, Inc. (HROW) | 2025-12-31 | $272.30M | +36.4% |
| Vireo Growth Inc. (VREOF) | 2025-12-31 | $268.77M | +170.4% |
| Ligand Pharmaceuticals Inc (LGND) | 2025-12-31 | $268.09M | +60.4% |
| Arvinas, Inc. (ARVN) | 2025-12-31 | $262.60M | -0.3% |
Compare CRMD, EOLS, IRWD, XERS side by side · Screen every company in Pharmaceutical Preparations ↗